LeMaitre Vascular (LMAT)
(Delayed Data from NSDQ)
$89.96 USD
-0.22 (-0.24%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $89.90 -0.06 (-0.07%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth C Momentum D VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 25% (63 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.69 | 9.99 |
Current Quarter Estimate | 0.44 | 7.55 | 61.00 |
Year Ago Quarter Estimate | 0.33 | 4.52 | 54.84 |
Next Quarter Estimate | 0.46 | 8.31 | 63.00 |
Next Year Estimate | 2.09 | 45.15 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 37.04 | 12.40 | 15.67 |
Next Year | 12.97 | 22.20 | 11.34 |
Last 5 Years | 9.40 | 2.90 | 8.10 |
Next 5 Years | 20.50 | 15.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 53.87 | 4.88 |
Price/Book (MRQ) | 6.32 | 2.18 |
Price/Cash Flow (MRFY) | 50.38 | 11.77 |
Dividend Yield | 0.71% | 0.00% |
Net Profit Margin (TTM) | 18.33% | -9.36% |
Return on Equity (TTM) | 12.41% | -3.53% |
Debt to Equity (MRQ) | 0.00 | 23.08 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.